Modern understanding of risk factors and mechanisms of breast cancer development

Q4 Pharmacology, Toxicology and Pharmaceutics
N. P. Pavlova, S. S. Dyomin, M. I. Churnosov, I. V. Ponomarenko
{"title":"Modern understanding of risk factors and mechanisms of breast cancer development","authors":"N. P. Pavlova, S. S. Dyomin, M. I. Churnosov, I. V. Ponomarenko","doi":"10.17650/2313-805x-2023-10-3-15-23","DOIUrl":null,"url":null,"abstract":"The article presents current data on the etiopathogenesis and risk factors of breast cancer (BC). The search for the sources was carried out in the PubMed, Medline, Cochrane Library, eLIBRARY, NHGRI-EBI Catalog of GWAS systems, publications from January 2000 to December 2022 were included. The interaction of definite risk factors, endocrine stimuli and genetic disorders causes activation / inactivation of various signaling pathways that directly or indirectly affect carcinogenesis. According to modern genetic evaluations, the contribution of the hereditary component to the formation of BC reaches 40 %. Interactiones between various risk factors form several molecular subtypes of breast carcinomas, differing in receptor status and clinical course, as well as therapeutic approaches. The details of the interaction of etiopathogenetic factors of BC are not clear, and often have a multidirectional character. Matrix metalloproteinases (MMPs) regulate the mechanisms of proliferation and apoptosis, invasion and metastasis, formation of the tumor microenvironment, neoangiogenesis, as well as intergenic signaling interactions, being an important link in the pathogenesis of BC.","PeriodicalId":36087,"journal":{"name":"Uspehi Molekularnoj Onkologii","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Uspehi Molekularnoj Onkologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2313-805x-2023-10-3-15-23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

The article presents current data on the etiopathogenesis and risk factors of breast cancer (BC). The search for the sources was carried out in the PubMed, Medline, Cochrane Library, eLIBRARY, NHGRI-EBI Catalog of GWAS systems, publications from January 2000 to December 2022 were included. The interaction of definite risk factors, endocrine stimuli and genetic disorders causes activation / inactivation of various signaling pathways that directly or indirectly affect carcinogenesis. According to modern genetic evaluations, the contribution of the hereditary component to the formation of BC reaches 40 %. Interactiones between various risk factors form several molecular subtypes of breast carcinomas, differing in receptor status and clinical course, as well as therapeutic approaches. The details of the interaction of etiopathogenetic factors of BC are not clear, and often have a multidirectional character. Matrix metalloproteinases (MMPs) regulate the mechanisms of proliferation and apoptosis, invasion and metastasis, formation of the tumor microenvironment, neoangiogenesis, as well as intergenic signaling interactions, being an important link in the pathogenesis of BC.
乳腺癌发展的危险因素和机制的现代认识
本文介绍了乳腺癌(BC)的发病机制和危险因素的最新数据。在PubMed, Medline, Cochrane Library, eLIBRARY, NHGRI-EBI GWAS系统目录中搜索来源,包括2000年1月至2022年12月的出版物。确定的危险因素、内分泌刺激和遗传疾病的相互作用导致直接或间接影响癌变的各种信号通路的激活/失活。根据现代遗传学评估,遗传成分对BC形成的贡献达到40%。各种危险因素之间的相互作用形成了乳腺癌的几种分子亚型,在受体状态和临床病程以及治疗方法上都有所不同。BC的发病因素相互作用的细节尚不清楚,往往具有多向性。基质金属蛋白酶(Matrix metalloproteinases, MMPs)调节肿瘤细胞增殖与凋亡、侵袭转移、肿瘤微环境形成、新生血管生成以及基因间信号相互作用等机制,是BC发病的重要环节。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Uspehi Molekularnoj Onkologii
Uspehi Molekularnoj Onkologii Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
CiteScore
0.40
自引率
0.00%
发文量
28
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信